semaglutide patent expiration canada The upcoming expiry of the in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open India Obesity Crisis: The Expiry

Since retatrutide is not yet available, tirzepatide is the next best option among approved medications, as it produces greater liver fat reductions than semaglutide

They can provide tailored advice considering factors such as your specific health condition and desired outcomes

Prompt clinical monitoring can stabilize blood sugar level changes before they worsen

A second attempt for approval was rejected in 2020, but Intarcia stuck with the product, refiling it once again, but was knocked back again last year when the FDA said it was planning to deny approval as deficiencies in the application had not been addressed